Adrenal disease

Simultaneous Liquid Chromatography-Tandem Mass Spectrometry Quantification of Cortisol and Dexamethasone Establishes a Platform-Specific Dexamethasone Lower Limit and Improves Diagnostic Specificity of the 1-mg Overnight Dexamethasone Suppression Test

Endocr PractPublished Prospective diagnostic accuracy study

Authors' conclusion

Concurrent LC-MS/MS measurement of Dex and cortisol enables assay-specific and population-specific Dex LLNs that, when applied, reduce false-positive DST interpretations with minimal impact on sensitivity. Reporting Dex alongside cortisol and flagging samples below LLN may improve clinical DST interpretation.

Study context

Population
Post-DST serum samples with measurable cortisol and dexamethasone (Dex) via LC-MS/MS, 1-mg overnight dexamethasone suppression test (DST) for Cushing's syndrome (CS) screening
Participants
221 post-DST serum samples
Comparison
Post-DST cortisol interpretation before vs after excluding samples with Dex < LLN (LC-MS/MS)
  • CSn = 80
  • Adrenal incidentalomasn = 93
  • Controlsn = 48reference
Outcome
Diagnostic performance of post-DST cortisol before and after excluding samples with Dex < LLN2.5% (primary threshold)

Performance

As reported in the abstract

Post-DST cortisol for identifying CS

AUC of post-DST cortisol for CS, all samples

0.96

95% CI 0.93–0.98

Further findings

Dex LLN values (non-CS, post-DST cortisol ≤ 1.8 μg/dL, n = 88)

ng/mL

LLN2.5%
1.706
LLN5%
1.889
LLN10%
2.399

Dex levels across samples

Dex range: below detection to
32.85 ng/mL
Median Dex
3.61 ng/mL
Undetectable Dex
4 samples (1.7%)
Excluded with Dex < LLN2.5%
21 samples (9.50%)
Samples remaining
200

Sensitivity analyses at LLN5% and LLN10%

Results consistent across other LLN thresholds

Original publication

Simultaneous Liquid Chromatography-Tandem Mass Spectrometry Quantification of Cortisol and Dexamethasone Establishes a Platform-Specific Dexamethasone Lower Limit and Improves Diagnostic Specificity of the 1-mg Overnight Dexamethasone Suppression Test. Endocr Pract. Published 30 December 2025. doi:10.1016/j.eprac.2025.12.017

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.